• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Adaptimmune Therapeutics plc - American Depositary Shares (NQ: ADAP )

    0.5788 -0.0092 (-1.56%)
    Streaming Delayed Price Updated: 1:00 PM EST, Dec 24, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 1,198,355
    Open 0.5810
    Bid (Size) 0.5900 (24)
    Ask (Size) 0.6056 (13)
    Prev. Close 0.5880
    Today's Range 0.5751 - 0.5900
    52wk Range 0.5005 - 2.050
    Shares Outstanding 1,535,299,242
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Adaptimmune Announces Changes to its Executive Leadership Team Based in The UK
    Helen Tayton-Martin, Ph.D., M.B.A, Adaptimmune Co-Founder and Chief Business & Strategy Officer, will step down from the Company March 31,... 
    Via Newsfile
    Topics Initial Public Offering
    Exposures Securities Market
    First Patient Treated with Adaptimmune's TECELRA(R) (afamitresgene autoleucel)
    Philadelphia, Pennsylvania and Oxford, United Kingdom--(Newsfile Corp. - December 2, 2024) - Adaptimmune Therapeutics plc (NASDAQ: ADAP), a company... 
    Via Newsfile

    Performance

    YTD
    -22.41%
    -22.41%
    1 Month
    -16.97%
    -16.97%
    3 Month
    -40.39%
    -40.39%
    6 Month
    -33.16%
    -33.16%
    1 Year
    -0.96%
    -0.96%

    More News

    Read More
    Demystifying Adaptimmune Therapeutics: Insights From 4 Analyst Reviews
    Via Benzinga
    Adaptimmune Reports Q3 2024 Financial and Business Updates
    Via Newsfile
    Adaptimmune's Lete-cel Achieves Primary Endpoint in Pivotal Trial
    Via Newsfile
    Earnings Scheduled For November 13, 2024
    Via Benzinga
    An Overview of Adaptimmune Therapeutics's Earnings
    Via Benzinga
    The Latest Analyst Ratings For Adaptimmune Therapeutics
    Via Benzinga
    Why Adaptimmune Therapeutics (ADAP) Stock Is Moving
    Via Benzinga
    Adaptimmune to Participate in Scientific and Medical Conferences this November and December
    Via Newsfile
    Adaptimmune to Report Q3 2024 Financial and Business Updates on Wednesday, November 13, 2024
    Via Newsfile
    Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing
    From Virtual Investor Conferences
    Via GlobeNewswire
    Life Sciences Virtual Investor Forum Agenda Announced for September 19th
    From Virtual Investor Conferences
    Via GlobeNewswire
    Adaptimmune to Participate in Two Bank Conferences this September
    Via Newsfile
    ADAP Stock Earnings: Adaptimmune Therapeutics Beats EPS, Beats Revenue for Q2 2024
    Via InvestorPlace
    Adaptimmune Reports Q2 2024 Financial and Business Updates
    Via Newsfile
    Exposures Product Safety
    Why Ainos Shares Are Trading Higher By Around 38%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    FDA Approves Adaptimmune Therapeutics' Engineered Cell Therapy As First For Solid Tumor And New Therapy For Rare Soft Tissue Cancer In Over A Decade
    Via Benzinga
    Exposures Product Safety
    Adaptimmune Receives U.S. FDA Accelerated Approval of TECELRA® (afamitresgene autoleucel), the First Approved Engineered Cell Therapy for a Solid Tumor
    From Adaptimmune Therapeutics plc
    Via Business Wire
    3 Biotech Moonshots With Imminent Catalyst Potential
    Via InvestorPlace
    Adaptimmune to Present Data from Planned Interim Analysis of Pivotal IGNYTE-ESO Trial with Lete-cel at ASCO; Data Continue to Support further Development of Sarcoma Franchise
    Via Newsfile
    Intelligent Bio Solutions Inc. (NASDAQ: INBS) Advancing US FDA Process, Featured Among Top Health Care Movers
    Via AB Newswire
    Exposures Product Safety
    12 Health Care Stocks Moving In Friday's Pre-Market Session
    Via Benzinga
    Why SentinelOne Shares Are Trading Lower By 16%? Here Are Other Stocks Moving In Friday's Mid-Day Session
    Via Benzinga
    Why Zscaler Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.